1 - 25 of 34 results for author:"Morin P.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (10)
| The growth response to androgen receptor signaling in ERalpha-negative human breast cells is dependent on p21 and mediated by MAPK activation. Garay J.P., Karakas B., Abukhdeir A.M., Cosgrove D.P., Gustin J.P., Higgins M.J., Konishi H., Konishi Y., Lauring J., Mohseni M. et al. Breast Cancer Res. 14:R27-R27(2012) · Mapped (11) |
| Pyroglutamate-Abeta 3 and 11 colocalize in amyloid plaques in Alzheimer's disease cerebral cortex with pyroglutamate-Abeta 11 forming the central core. Sullivan C.P., Berg E.A., Elliott-Bryant R., Fishman J.B., McKee A.C., Morin P.J., Shia M.A., Fine R.E. Neurosci. Lett. 505:109-112(2011) · Mapped (10) |
| Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion. Dahiya N., Becker K.G., Wood W.H., Zhang Y., Morin P.J. PLoS ONE 6:e22119-e22119(2011) · Mapped (2) |
| Retromer disruption promotes amyloidogenic APP processing. Sullivan C.P., Jay A.G., Stack E.C., Pakaluk M., Wadlinger E., Fine R.E., Wells J.M., Morin P.J. Neurobiol. Dis. 43:338-345(2011) · Mapped (13) |
| Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Camilli T.C., Xu M., O'Connell M.P., Chien B., Frank B.P., Subaran S., Indig F.E., Morin P.J., Hewitt S.M., Weeraratna A.T. Pigment Cell Melanoma Res 24:175-186(2011) · Mapped (4) |
| Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes. Mello Coelho V., Bunbury A., Rangel L.B., Giri B., Weeraratna A., Morin P.J., Bernier M., Taub D.D. Int J Med Sci 7:1-14(2009) · Mapped (9) |
| Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. Agarwal R., Mori Y., Cheng Y., Jin Z., Olaru A.V., Hamilton J.P., David S., Selaru F.M., Yang J., Abraham J.M. et al. PLoS ONE 4:e8002-e8002(2009) · Mapped (2) |
| Possible angiogenic roles for claudin-4 in ovarian cancer. Li J., Chigurupati S., Agarwal R., Mughal M.R., Mattson M.P., Becker K.G., Wood W.H., Zhang Y., Morin P.J. Cancer Biol. Ther. 8:1806-1814(2009) · Mapped (4) |
| Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. Li J., Sherman-Baust C.A., Tsai-Turton M., Bristow R.E., Roden R.B., Morin P.J. BMC Cancer 9:244-244(2009) · Mapped (4) |
| Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Honda H., Barrueto F.F., Gogusev J., Im D.D., Morin P.J. Reprod. Biol. Endocrinol. 6:59-59(2008) · Mapped (12) |
| Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. Choi J.H., Park J.T., Davidson B., Morin P.J., Shih I.e.M., Wang T.L. Cancer Res. 68:5716-5723(2008) · Mapped (8) |
| Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Konecny G.E., Agarwal R., Keeney G.A., Winterhoff B., Jones M.B., Mariani A., Riehle D., Neuper C., Dowdy S.C., Wang H.J. et al. Gynecol. Oncol. 109:263-269(2008) · Mapped (6) |
| Regulation of the CLDN3 gene in ovarian cancer cells. Honda H., Pazin M.J., D'Souza T., Ji H., Morin P.J. Cancer Biol. Ther. 6:1733-1742(2007) · Mapped (2) |
| Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells. D'Souza T., Indig F.E., Morin P.J. Exp. Cell Res. 313:3364-3375(2007) · Mapped (7) |
| Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. Zhu T.N., He H.J., Kole S., D'Souza T., Agarwal R., Morin P.J., Bernier M. J. Biol. Chem. 282:14816-14826(2007) · Mapped (18) |
| A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Nakayama K., Nakayama N., Davidson B., Sheu J.-J.C., Jinawath N., Santillan A., Salani R., Bristow R.E., Morin P.J., Kurman R.J. et al. Proc. Natl. Acad. Sci. U.S.A. 103:18739-18744(2006) · UniProtKB (2) |
| Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells. Li J., Wood W.H., Becker K.G., Weeraratna A.T., Morin P.J. Oncogene 26:2860-2872(2007) · Mapped (6) |
| Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. Honda H., Pazin M.J., Ji H., Wernyj R.P., Morin P.J. J. Biol. Chem. 281:21433-21444(2006) · Mapped (11) |
| Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. D'Souza T., Agarwal R., Morin P.J. J. Biol. Chem. 280:26233-26240(2005) · UniProtKB (1) · Mapped (4) |
| Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Wali A., Morin P.J., Hough C.D., Lonardo F., Seya T., Carbone M., Pass H.I. Lung Cancer 48:19-29(2005) · Mapped (2) |
| Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Chen Y.C., Pohl G., Wang T.L., Morin P.J., Risberg B., Kristensen G.B., Yu A., Davidson B., Shih I.e.M. Cancer Res. 65:331-337(2005) · Mapped (5) |
| Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers. Rangel L.B., Agarwal R., Sherman-Baust C.A., Mello-Coelho V., Pizer E.S., Ji H., Taub D.D., Morin P.J. Cancer Biol. Ther. 3:1021-1027(2004) · Mapped (11) |
| Wnt-1 expression in PC12 cells induces exon 15 deletion and expression of L-APP. Morin P.J., Medina M., Semenov M., Brown A.M., Kosik K.S. Neurobiol. Dis. 16:59-67(2004) · Mapped (3) |
| Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Yang Y.A., Morin P.J., Han W.F., Chen T., Bornman D.M., Gabrielson E.W., Pizer E.S. Exp. Cell Res. 282:132-137(2003) · Mapped (15) |
| Renal cell carcinoma: taking care of business. Morin P.J. Cancer Biol. Ther. 1:537-538(2002) · Mapped (30) |